Cargando…

Towards optimised extracellular vesicle proteomics from cerebrospinal fluid

The proteomic profile of extracellular vesicles (EVs) from cerebrospinal fluid (CSF) can reveal novel biomarkers for diseases of the brain. Here, we validate an ultrafiltration combined with size-exclusion chromatography (UF-SEC) method for isolation of EVs from canine CSF and probe the effect of st...

Descripción completa

Detalles Bibliográficos
Autores principales: Kangas, Petra, Nyman, Tuula A., Metsähonkala, Liisa, Burns, Cameron, Tempest, Robert, Williams, Tim, Karttunen, Jenni, Jokinen, Tarja S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261101/
https://www.ncbi.nlm.nih.gov/pubmed/37308520
http://dx.doi.org/10.1038/s41598-023-36706-z
_version_ 1785057881123454976
author Kangas, Petra
Nyman, Tuula A.
Metsähonkala, Liisa
Burns, Cameron
Tempest, Robert
Williams, Tim
Karttunen, Jenni
Jokinen, Tarja S.
author_facet Kangas, Petra
Nyman, Tuula A.
Metsähonkala, Liisa
Burns, Cameron
Tempest, Robert
Williams, Tim
Karttunen, Jenni
Jokinen, Tarja S.
author_sort Kangas, Petra
collection PubMed
description The proteomic profile of extracellular vesicles (EVs) from cerebrospinal fluid (CSF) can reveal novel biomarkers for diseases of the brain. Here, we validate an ultrafiltration combined with size-exclusion chromatography (UF-SEC) method for isolation of EVs from canine CSF and probe the effect of starting volume on the EV proteomics profile. First, we performed a literature review of CSF EV articles to define the current state of art, discovering a need for basic characterisation of CSF EVs. Secondly, we isolated EVs from CSF by UF-SEC and characterised the SEC fractions by protein amount, particle count, transmission electron microscopy, and immunoblotting. Data are presented as mean ± standard deviation. Using proteomics, SEC fractions 3–5 were compared and enrichment of EV markers in fraction 3 was detected, whereas fractions 4–5 contained more apolipoproteins. Lastly, we compared starting volumes of pooled CSF (6 ml, 3 ml, 1 ml, and 0.5 ml) to evaluate the effect on the proteomic profile. Even with a 0.5 ml starting volume, 743 ± 77 or 345 ± 88 proteins were identified depending on whether ‘matches between runs’ was active in MaxQuant. The results confirm that UF-SEC effectively isolates CSF EVs and that EV proteomic analysis can be performed from 0.5 ml of canine CSF.
format Online
Article
Text
id pubmed-10261101
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-102611012023-06-15 Towards optimised extracellular vesicle proteomics from cerebrospinal fluid Kangas, Petra Nyman, Tuula A. Metsähonkala, Liisa Burns, Cameron Tempest, Robert Williams, Tim Karttunen, Jenni Jokinen, Tarja S. Sci Rep Article The proteomic profile of extracellular vesicles (EVs) from cerebrospinal fluid (CSF) can reveal novel biomarkers for diseases of the brain. Here, we validate an ultrafiltration combined with size-exclusion chromatography (UF-SEC) method for isolation of EVs from canine CSF and probe the effect of starting volume on the EV proteomics profile. First, we performed a literature review of CSF EV articles to define the current state of art, discovering a need for basic characterisation of CSF EVs. Secondly, we isolated EVs from CSF by UF-SEC and characterised the SEC fractions by protein amount, particle count, transmission electron microscopy, and immunoblotting. Data are presented as mean ± standard deviation. Using proteomics, SEC fractions 3–5 were compared and enrichment of EV markers in fraction 3 was detected, whereas fractions 4–5 contained more apolipoproteins. Lastly, we compared starting volumes of pooled CSF (6 ml, 3 ml, 1 ml, and 0.5 ml) to evaluate the effect on the proteomic profile. Even with a 0.5 ml starting volume, 743 ± 77 or 345 ± 88 proteins were identified depending on whether ‘matches between runs’ was active in MaxQuant. The results confirm that UF-SEC effectively isolates CSF EVs and that EV proteomic analysis can be performed from 0.5 ml of canine CSF. Nature Publishing Group UK 2023-06-12 /pmc/articles/PMC10261101/ /pubmed/37308520 http://dx.doi.org/10.1038/s41598-023-36706-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Kangas, Petra
Nyman, Tuula A.
Metsähonkala, Liisa
Burns, Cameron
Tempest, Robert
Williams, Tim
Karttunen, Jenni
Jokinen, Tarja S.
Towards optimised extracellular vesicle proteomics from cerebrospinal fluid
title Towards optimised extracellular vesicle proteomics from cerebrospinal fluid
title_full Towards optimised extracellular vesicle proteomics from cerebrospinal fluid
title_fullStr Towards optimised extracellular vesicle proteomics from cerebrospinal fluid
title_full_unstemmed Towards optimised extracellular vesicle proteomics from cerebrospinal fluid
title_short Towards optimised extracellular vesicle proteomics from cerebrospinal fluid
title_sort towards optimised extracellular vesicle proteomics from cerebrospinal fluid
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10261101/
https://www.ncbi.nlm.nih.gov/pubmed/37308520
http://dx.doi.org/10.1038/s41598-023-36706-z
work_keys_str_mv AT kangaspetra towardsoptimisedextracellularvesicleproteomicsfromcerebrospinalfluid
AT nymantuulaa towardsoptimisedextracellularvesicleproteomicsfromcerebrospinalfluid
AT metsahonkalaliisa towardsoptimisedextracellularvesicleproteomicsfromcerebrospinalfluid
AT burnscameron towardsoptimisedextracellularvesicleproteomicsfromcerebrospinalfluid
AT tempestrobert towardsoptimisedextracellularvesicleproteomicsfromcerebrospinalfluid
AT williamstim towardsoptimisedextracellularvesicleproteomicsfromcerebrospinalfluid
AT karttunenjenni towardsoptimisedextracellularvesicleproteomicsfromcerebrospinalfluid
AT jokinentarjas towardsoptimisedextracellularvesicleproteomicsfromcerebrospinalfluid